Narayana Hrudayalaya’s board has approved the unaudited financial results for Q2 ended September 30, 2025. Consolidated revenue from operations reached ₹16,437.90 million, while net profit was ₹2,584.95 million. The results reflect ongoing growth in medical and healthcare services, and the company remains focused on expanding its integrated healthcare ecosystem and delivering value to its stakeholders.
Financial Performance Highlights
The Board of Directors of Narayana Hrudayalaya approved the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2025. Key figures from the consolidated results include:
- Revenue from Operations: ₹16,437.90 million
- Total Income: ₹16,677.82 million
- Net Profit: ₹2,584.95 million
Standalone Financials
Key highlights from the unaudited standalone financial results:
- Revenue from Operations: ₹10,191.69 million
- Total Income: ₹10,362.57 million
The earnings per share for continuing operations is ₹12.71.
Segmental Performance
The company’s operating segments include Medical and Healthcare Related Services and Others (Insurance Segment). Medical and Healthcare Related Services generated revenue of ₹16,098.60 million in Q2.
Merger and Acquisitions
The Scheme of Arrangement for the Merger of Meridian Medical Research & Hospital Ltd. (MMRHL) with Narayana Hrudayalaya is progressing. The next hearing is scheduled to be held in due course to decide the process for convening the Court convened meetings of the shareholders and the creditors.
Source: BSE